SUBSCRIBE
SUBSCRIBE

Palleon Pharmaceuticals

NEWS
Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million
Genetown
Palleon Pharma Bursts Onto the Scene With $47.6 Million and a New R&D Approach
October 4, 2017
 · 
2 min read
IN THE PRESS
Business
Palleon Pharmaceuticals Appoints Li Peng, Ph.D., as Chief Scientific Officer
February 12, 2020
 · 
2 min read
Drug Development
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody Programs at the 11th Annual Protein & Antibody Engineering Summit
November 19, 2019
 · 
2 min read
Drug Development
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE and HYDRA Platforms at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting
November 7, 2019
 · 
3 min read
Policy
Palleon Pharmaceuticals Announces Successful Defense of European Patent
February 6, 2019
 · 
2 min read
Genetown
Palleon Pharmaceuticals Announces Preclinical Data from EAGLE Platform to be Presented at the AACR Special Conference on Tumor Immunology and Immunotherapy
November 26, 2018
 · 
3 min read
Drug Development
Palleon Pharmaceuticals Announces Preclinical Data from EAGLE Platform to be Presented at the Society for Immunotherapy of Cancer Annual Meeting
November 8, 2018
 · 
3 min read
Business
Palleon Pharmaceuticals Appoints Lori Hu of Vertex Ventures HC to Board of Directors
June 21, 2018
 · 
2 min read
Business
Palleon Pharmaceuticals Signs Exclusive License Agreement with King’s College London for Intellectual Property Related to Glycoimmune Checkpoints to Treat Cancer
December 12, 2017
 · 
3 min read
Load More
JOBS